Evidence map›Paper›PMID 42191984›Full record

ArticleBone marrow transplantation2026

Low-positive CMV IgG serostatus before allogeneic hematopoietic cell transplantation is not associated with increased CMV reactivation risk.

Klaudia Nägele, Carla Walti, Rainer Gosert, Meret Katharina Schmidhauser, Annika Bargetzi, Dominic Mills, Jakob Passweg, Joerg Halter, Francesca Matteazzi, Veronika Baettig and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Klaudia Nägele *Clinical Virology, University Hospital Basel, Basel, Switzerland.
Carla Walti *Division of Infectious Diseases, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-0750-2543
Rainer GosertClinical Virology, University Hospital Basel, Basel, Switzerland.
Meret Katharina SchmidhauserInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0003-4765-1743
Annika BargetziDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.
Dominic MillsInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Jakob PasswegHematology, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0001-7092-3351
Joerg HalterHematology, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0003-4304-1956
Francesca MatteazziHematology, University Hospital Basel, Basel, Switzerland.
Veronika BaettigDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.
Guido Vincent BloembergInstitute of Medical Virology, University of Zurich, Zurich, Switzerland.
Nina KhannaDivision of Infectious Diseases, University Hospital Basel, Basel, Switzerland.ORCID http://orcid.org/0000-0002-2642-419X
Karoline LeuzingerClinical Virology, University Hospital Basel, Basel, Switzerland. karoline.leuzinger@usb.ch.ORCID http://orcid.org/0000-0002-5654-9356

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42191984
PMCPMC13349850

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.